these data show that somatostatin can suppress glucose-induced hypoglycemia in these subjects , thus suggesting that its long-acting analogues might be worth a therapeutic trial in severe idiopathic postprandial hypoglycemia .
C0017725
glucose
C0020615
hypoglycemia